Life Expectancy of Insured People With and Without Hepatitis C Virus Infection, 2007-2017.
direct-acting antiviral agents
hepatitis C virus (HCV)
mortality
survival
treatment
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
10
01
2020
accepted:
04
02
2020
entrez:
5
3
2020
pubmed:
5
3
2020
medline:
5
3
2020
Statut:
epublish
Résumé
Among 25 291 and 4 921 830 people with and without hepatitis C, life expectancy at age 20 increased 1.8 years and 0.3 years from the interferon to interferon-free era, respectively. Increases were highest for racial and/or ethnic minority groups with hepatitis C.
Identifiants
pubmed: 32128339
doi: 10.1093/ofid/ofaa044
pii: ofaa044
pmc: PMC7043807
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofaa044Subventions
Organisme : NIAID NIH HHS
ID : K01 AI122853
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
J Virus Erad. 2019 Sep 18;5(3):138-144
pubmed: 31700657
Hepatology. 2018 Sep;68(3):827-838
pubmed: 29377196
Public Health Rep. 2018 Jul/Aug;133(4):452-460
pubmed: 29750893
JAMA Netw Open. 2019 Jun 5;2(6):e194765
pubmed: 31173117
Health Aff (Millwood). 2019 Feb;38(2):287-294
pubmed: 30715966
Clin Infect Dis. 2016 May 15;62(10):1287-1288
pubmed: 26936668
Natl Vital Stat Rep. 2017 Aug;66(4):1-64
pubmed: 29155687
Clin Infect Dis. 2017 Nov 13;65(11):1773-1775
pubmed: 29020156
Cochrane Database Syst Rev. 2017 Sep 18;9:CD012143
pubmed: 28922704